Nasdaq Biotechnology Ishares (IBB) 252.43 $IBB
Stock Market Today: Social Media, Biotech Suffer as Janet Yellen Shares Concerns on Valuation
at The Street - Tue Jul 15, 3:19PM CDT
Major indices trembled and the Nasdaq slid Tuesday following Fed Chair Janet Yellen's remarks on biotech and social media valuations.
Fed: These Two Industries Look Overvalued - Real Time Insight
Todd Bunton - Zacks Investment Research - Tue Jul 15, 1:29PM CDT
In a recent report to Congress, the Fed highlighted "stretched" valuations in two specific industries.
Fed Chair Yellen Says Small Biotech Stocks Over-Valued
at The Street - Tue Jul 15, 12:10PM CDT
Biotech indices plunge on cautious remarks made by Fed Chairwoman during Congressional testimony.
Stock Market Today: Biotech, Social Media Stocks Slide Following Yellen's Remarks
at The Street - Tue Jul 15, 11:14AM CDT
Major U.S. stock markets slide Tuesday following Fed Chair Janet Yellen's remarks on biotech and social media valuations.
Earnings Preview: Abbott Laboratories and Johnson & Johnson
George Budwell, The Motley Fool - Motley Fool - Mon Jul 14, 1:30PM CDT
The health care sector in general, and biotech industry in particular, have now shrugged off their earlier first quarter dip. For instance, the iShares Nasdaq Biotech Index has rallied a little over 13% year to date, although this closely watched...
'Fast Money' Recap: Confusion in the Market
at The Street - Fri Jul 11, 4:00AM CDT
The trading panel discussed whether investors are too complacent and whether it's a good idea to buy Microsoft again.
'Fast Money' Recap: Digging Into Oil Prices
at The Street - Thu Jul 10, 4:00AM CDT
The trading panel looked at whether WTI will go lower, how that will affect transportation stocks and how successful a Kim Kardashian mobile game app can be.
iShares Nasdaq Biotechnology Index Falls 2.14% on Heavy Volume: Watch For Potential Rebound
Comtex SmarTrend(R) - Tue Jul 08, 4:32PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $251.76 to a high of $258.50. Yesterday, the shares fell 2.1%, which took the trading range below the 3-day low of $258.83 on volume of 2.2 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
SmarTrend Watching for Potential Rebound in Shares of iShares Nasdaq Biotechnology Index After 2.14% Loss
Comtex SmarTrend(R) - Tue Jul 08, 4:31PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $251.76 to a high of $258.50. Yesterday, the shares fell 2.1%, which took the trading range below the 3-day low of $258.83 on volume of 2.2 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
Today's 3 Most Volatile Biotech Stocks
Todd Campbell, The Motley Fool - Motley Fool - Tue Jul 08, 4:05PM CDT
Biotechnology stocks are never short on volatility and today was no different as markets turned lower and biotech stocks were particularly hard hit. The Nasdaq Biotechnology Index ETF dropped more than 2% as investors embraced safety and avoided...
Do Illumina and Incyte Belong in Your Portfolio?
Selena Maranjian, The Motley Fool - Motley Fool - Mon Jul 07, 5:15PM CDT
Source: Konrad Forstner, Wikimedia Commons. Exchange-traded funds offer a convenient way to invest in sectors or niches that interest you. If you'd like to add some biotech companies to your portfolio but don't have the time or expertise to...
12.9% Return Seen to Date on SmarTrend iShares Nasdaq Biotechnology Index Call (IBB)
Comtex SmarTrend(R) - Wed Jul 02, 9:22AM CDT
SmarTrend identified an Uptrend for iShares Nasdaq Biotechnology Index (AMEX:IBB) on April 22nd, 2014 at $232.92. In approximately 2 months, iShares Nasdaq Biotechnology Index has returned 12.92% as of today's recent price of $263.01.
SmarTrend Watching for Potential Pullback in Shares of iShares Nasdaq Biotechnology Index After 2.37% Gain
Comtex SmarTrend(R) - Tue Jul 01, 4:46PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $258.18 to a high of $263.30. Yesterday, the shares gained 2.4%, which took the trading range above the 3-day high of $258.12 on volume of 1.1 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
Watch for iShares Nasdaq Biotechnology Index to Potentially Pullback After Gaining 2.37% Yesterday
Comtex SmarTrend(R) - Tue Jul 01, 4:45PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $258.18 to a high of $263.30. Yesterday, the shares gained 2.4%, which took the trading range above the 3-day high of $258.12 on volume of 1.1 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
3 Stocks Tumbling This Month: Clovis Oncology, Hyperion Therapeutics, and Puma Biotechnology
Todd Campbell, The Motley Fool - Motley Fool - Mon Jun 30, 3:12PM CDT
Shares in biotechnology companies can make breathtaking moves higher and lower on whims and whispers and June was no exception. Following a rollicking ride higher last year and dramatic sell-off in the first quarter, investors are right to be...
3 Stocks With Eye-Popping Gains This Month
Todd Campbell, The Motley Fool - Motley Fool - Mon Jun 30, 2:12PM CDT
Shares in biotechnology companies can make breathtaking moves higher and lower on whims and whispers, and June was no exception. Following the sector's rollicking ride higher last year and dramatic sell-off in the first quarter, investors are right...
Vertex Pharma Pushes Biotech ETFs Higher - ETF News And Commentary
Sweta Killa - ZACKS - Wed Jun 25, 1:00PM CDT
The positive trial results of a cystic fibrosis send Vertex Pharmaceuticals and these biotech ETFs higher on Tuesday trading session.
'Fast Money' Recap: A Mixed Bag for Housing
at The Street - Wed Jun 25, 4:00AM CDT
The trading panel discussed the stock market's big drop, how low the S&P can go and why bonds aren't selling off.
Stock Market Today: Social Media, Biotech Suffer as Janet Yellen Shares Concerns on Valuation
at The Street - Tue Jul 15, 3:19PM CDT
Major indices trembled and the Nasdaq slid Tuesday following Fed Chair Janet Yellen's remarks on biotech and social media valuations.
Fed: These Two Industries Look Overvalued - Real Time Insight
Todd Bunton - Zacks Investment Research - Tue Jul 15, 1:29PM CDT
In a recent report to Congress, the Fed highlighted "stretched" valuations in two specific industries.
Fed Chair Yellen Says Small Biotech Stocks Over-Valued
at The Street - Tue Jul 15, 12:10PM CDT
Biotech indices plunge on cautious remarks made by Fed Chairwoman during Congressional testimony.
Stock Market Today: Biotech, Social Media Stocks Slide Following Yellen's Remarks
at The Street - Tue Jul 15, 11:14AM CDT
Major U.S. stock markets slide Tuesday following Fed Chair Janet Yellen's remarks on biotech and social media valuations.
Earnings Preview: Abbott Laboratories and Johnson & Johnson
George Budwell, The Motley Fool - Motley Fool - Mon Jul 14, 1:30PM CDT
The health care sector in general, and biotech industry in particular, have now shrugged off their earlier first quarter dip. For instance, the iShares Nasdaq Biotech Index has rallied a little over 13% year to date, although this closely watched...
'Fast Money' Recap: Confusion in the Market
at The Street - Fri Jul 11, 4:00AM CDT
The trading panel discussed whether investors are too complacent and whether it's a good idea to buy Microsoft again.
'Fast Money' Recap: Digging Into Oil Prices
at The Street - Thu Jul 10, 4:00AM CDT
The trading panel looked at whether WTI will go lower, how that will affect transportation stocks and how successful a Kim Kardashian mobile game app can be.
iShares Nasdaq Biotechnology Index Falls 2.14% on Heavy Volume: Watch For Potential Rebound
Comtex SmarTrend(R) - Tue Jul 08, 4:32PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $251.76 to a high of $258.50. Yesterday, the shares fell 2.1%, which took the trading range below the 3-day low of $258.83 on volume of 2.2 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
SmarTrend Watching for Potential Rebound in Shares of iShares Nasdaq Biotechnology Index After 2.14% Loss
Comtex SmarTrend(R) - Tue Jul 08, 4:31PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $251.76 to a high of $258.50. Yesterday, the shares fell 2.1%, which took the trading range below the 3-day low of $258.83 on volume of 2.2 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
Today's 3 Most Volatile Biotech Stocks
Todd Campbell, The Motley Fool - Motley Fool - Tue Jul 08, 4:05PM CDT
Biotechnology stocks are never short on volatility and today was no different as markets turned lower and biotech stocks were particularly hard hit. The Nasdaq Biotechnology Index ETF dropped more than 2% as investors embraced safety and avoided...
Do Illumina and Incyte Belong in Your Portfolio?
Selena Maranjian, The Motley Fool - Motley Fool - Mon Jul 07, 5:15PM CDT
Source: Konrad Forstner, Wikimedia Commons. Exchange-traded funds offer a convenient way to invest in sectors or niches that interest you. If you'd like to add some biotech companies to your portfolio but don't have the time or expertise to...
12.9% Return Seen to Date on SmarTrend iShares Nasdaq Biotechnology Index Call (IBB)
Comtex SmarTrend(R) - Wed Jul 02, 9:22AM CDT
SmarTrend identified an Uptrend for iShares Nasdaq Biotechnology Index (AMEX:IBB) on April 22nd, 2014 at $232.92. In approximately 2 months, iShares Nasdaq Biotechnology Index has returned 12.92% as of today's recent price of $263.01.
SmarTrend Watching for Potential Pullback in Shares of iShares Nasdaq Biotechnology Index After 2.37% Gain
Comtex SmarTrend(R) - Tue Jul 01, 4:46PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $258.18 to a high of $263.30. Yesterday, the shares gained 2.4%, which took the trading range above the 3-day high of $258.12 on volume of 1.1 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
Watch for iShares Nasdaq Biotechnology Index to Potentially Pullback After Gaining 2.37% Yesterday
Comtex SmarTrend(R) - Tue Jul 01, 4:45PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $258.18 to a high of $263.30. Yesterday, the shares gained 2.4%, which took the trading range above the 3-day high of $258.12 on volume of 1.1 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
3 Stocks Tumbling This Month: Clovis Oncology, Hyperion Therapeutics, and Puma Biotechnology
Todd Campbell, The Motley Fool - Motley Fool - Mon Jun 30, 3:12PM CDT
Shares in biotechnology companies can make breathtaking moves higher and lower on whims and whispers and June was no exception. Following a rollicking ride higher last year and dramatic sell-off in the first quarter, investors are right to be...
3 Stocks With Eye-Popping Gains This Month
Todd Campbell, The Motley Fool - Motley Fool - Mon Jun 30, 2:12PM CDT
Shares in biotechnology companies can make breathtaking moves higher and lower on whims and whispers, and June was no exception. Following the sector's rollicking ride higher last year and dramatic sell-off in the first quarter, investors are right...
Vertex Pharma Pushes Biotech ETFs Higher - ETF News And Commentary
Sweta Killa - ZACKS - Wed Jun 25, 1:00PM CDT
The positive trial results of a cystic fibrosis send Vertex Pharmaceuticals and these biotech ETFs higher on Tuesday trading session.
'Fast Money' Recap: A Mixed Bag for Housing
at The Street - Wed Jun 25, 4:00AM CDT
The trading panel discussed the stock market's big drop, how low the S&P can go and why bonds aren't selling off.
